Navigation Links
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
Date:7/23/2009

trial results is available on Rigel's website homepage athttp://www.rigel.com. To access the live call, please dial 1-866-700-6293 (domestic) or 1-617-213-8835 (international) 10 minutes prior to the start time and use the passcode 13318888. A replay of the call will be available at approximately 10:00 pm EDT/7:00 pm PDT on July 23, 2009 until July 30, 2009. To access the replay, please dial 1-888-286-8010 (domestic) or 1-617-801-6888 (international) and use the passcode 14211103. The conference call will also be webcast live and can be accessed from Rigel's website at http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary. Further information on R788 in RA is available at Rigel's website: http://www.rigel.com/rigel/rheumatoid_arthritis.

About Rigel (www.Rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory/autoimmune diseases and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "f
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DALLAS , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Crystallography Scanner Industry, 2009-2019 is a professional and ... X-Ray Crystallography Scanner industry . The report firstly ... including its classification, application and manufacturing technology. The ... of X-Ray Crystallography Scanner listing their product specification, ...
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP has ... or the "Company") (NASDAQ: EDAP ) and ... United States District Court, Southern District of ... on behalf of a class consisting of all persons ... 2013 and July 30, 2014, inclusive (the "Class Period"). This ...
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the nation,s ... Polaris Medical Imaging, a leader in sales, service and ... acquisition allows BC Technical to continue to expand their ... MR and CT modalities. "We are ... Mark Alvarez , president and CEO of BC ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3BC Technical Acquires Polaris Medical Imaging 2
(Date:8/30/2014)... (PRWEB) August 30, 2014 After ... the country for the past several years, Dr. ... Hyperbaric Center have announced a scholarship program for ... announcement follows a meeting held this summer to ... recent years, reporters have shed light on the ...
(Date:8/30/2014)... 30, 2014 Insomnia causes disturbances in every ... how they unknowingly developed insomnia and the steps often used ... Tune in to the show at this link: ... live on August 30, and will be podcasted at ... go to DrCarolFrancisTalkRadio.com. , "Insomnia causes countless unrecognized ...
(Date:8/30/2014)... "My wife suffered neck, back and spine ... one of two inventors from Bethel, Alaska. "The whiplash ... neck area. She tried other pillows to little avail. ... in comfort and providing extra sleep." , They created ... the head, neck and back comfortably. This enables the ...
(Date:8/30/2014)... Bringing forth the great opportunities, India's ... Labor Day discount on all SEO services. While working ... services related to internet marketing. Their dedicated team of ... do have a deep understanding for their specialization. This ... and since the inception, they have worked with over ...
(Date:8/30/2014)... 2014 In today’s world, a good ... to get. Snoring and sleep apnea (a medical problem ... robs people and their bed partners of the rest ... 45% of the population snores and 20 million people ... these, only 10% have been diagnosed and treated; and ...
Breaking Medicine News(10 mins):Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:Profit By Search Announces Labor Day Discount on SEO Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... Josh Kelley, analyst with,HealthLeaders-InterStudy, a leading provider of ... Bill Richardson,s healthcare,reform proposal in light of a ... 15. Gov. Richardson called the session following the ... budget surplus in New,Mexico., Mr. Kelley ...
... 6 Mylan Inc. (NYSE: MYL ),announced ... Famy Care Ltd, a,global, India-based manufacturing leader of ... oral contraceptive (OC) medicines to customers in,the United ... right of first,refusal for additional oral contraceptive products ...
... Full Year Revenue Guidance to a range of $410 Million to $420 ... Million ... of $109.8 million, up 57.5% over second quarter 2007 - Gross profit of $27.4 million, up ... 23.5% ...
... quarter ... up 79% from second quarter 2007, - Second quarter operating margin of 12.7%, up 160 bp from second quarter ... 2007, - Record new business awards of $204 million, up 24% from second quarter ... 2007, - Record total business authorizations of $979 million, up 13% from Dec. ...
... of Internet-based medical billing software for physician offices, hospitalists and ... ten participants. , ... Orlando, FL ... Internet-based http://www.collaboratemd.com/ [medical billing software] for physician offices, ...
... Explore the Evolution of Vulnerability Management and Operational Whitelisting ... , ... Scottsdale, ... [Lumension Security™ Inc. __title__ Vulnerability Management Solutions], a recognized, ...
Cached Medicine News:Health News:Mylan Creates New Women's Health Care Franchise; Signs Agreement with Famy Care to Develop and Supply 22 Oral Contraceptive Products 2Health News:Mylan Creates New Women's Health Care Franchise; Signs Agreement with Famy Care to Develop and Supply 22 Oral Contraceptive Products 3Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 2Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 3Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 4Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 5Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 6Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 7Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 8Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 9Health News:Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008 2Health News:Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008 3Health News:Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008 4Health News:Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008 5Health News:Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008 6Health News:Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008 7Health News:Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008 8Health News:CollaborateMD Launches New Value-Added Reseller (VAR) Program 2Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 2Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 3
... of P.falciparum specific histidine ... specific pLDH and pan malaria ... of P. falciparum and ... other malarial species and for the ...
... a two site sandwich immunoassay ... detection of P. falciparum specific ... and P. vivax specific pLDH. ... used for specific detection and ...
Malaria Pf. Assay Range...
ADVANTAGE MALARIA STIX is a visual, rapid and sensitive immunoassay for the qualitative differential detection of P.falciparum (P.f) and P.vivax (P.v) malaria in Human Blood only....
Medicine Products: